Clinical consequences of Cushing's syndrome (Q38004913)

26 August 2017

title

Clinical consequences of Cushing's syndrome (English)

1 reference

26 August 2017

Iris Crespo

2

0 references

Alicia Santos

object named as

Alicia Santos

series ordinal

3

0 references

Susan M Webb

object named as

Susan M Webb

series ordinal

4

0 references

author name string

Elena Valassi

series ordinal

1

1 reference

26 August 2017

publication date

1 September 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

15

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

319-329

1 reference

The metabolic syndrome and cardiovascular risk in Cushing's syndrome

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Glucocorticoid Regulation of Leptin Synthesis and Secretion in Humans: Elevated Plasma Leptin Levels in Cushing’s Syndrome1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Blood pressure in pediatric patients with Cushing syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Left ventricular structural and functional characteristics in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Increased arterial rigidity in children affected by Cushing's syndrome after successful surgical cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Hypercoagulable state in Cushing's syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Ghrelin, hypothalamus-pituitary-adrenal (HPA) axis and Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Glucocorticoid-induced osteoporosis: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Spine abnormalities and damage in patients cured from Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Increased risk of osteoporotic fractures in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Metabolic Syndrome and the Genesis of Uric Acid Stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Clinical correlates of major depression in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Elevated cortisol levels in Cushing's disease are associated with cognitive decrements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Improvement in mood and ideation associated with increase in right caudate volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

A new editor-in-chief at the Helm!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Psychological aspects of endocrine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Quality of life in patients with a pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Quality of life in patients after long-term biochemical cure of Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Incidence and late prognosis of cushing's syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Quality of life after laparoscopic bilateral adrenalectomy for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Long-term results of total adrenalectomy for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Long-term mortality after transsphenoidal surgery for Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Circadian Blood Pressure Profile in Patients with Active Cushing's Disease and after Long-term Cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11102-012-0394-8

Patterns of cognitive change over time and relationship to age following successful treatment of Cushing's disease

21 January 2018

1 reference

12 December 2020

Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery

1 reference

12 December 2020

Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome

1 reference

12 December 2020

Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results

1 reference

12 December 2020

Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome

1 reference

12 December 2020

Risk factors associated with persistent postoperative hypertension in Cushing's syndrome

1 reference

12 December 2020

Morbidity and mortality in Cushing's disease: an epidemiological approach

1 reference

12 December 2020

Body composition determined by six different methods in women bilaterally adrenalectomized for treatment of Cushing's disease

1 reference

12 December 2020

Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1

1 reference

12 December 2020

Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome

1 reference

12 December 2020

Persistent hypertension after successful adrenal operation

1 reference

12 December 2020

Cognitive decline in patients with Cushing's syndrome

1 reference

12 December 2020

Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism

1 reference

12 December 2020

Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease

1 reference

12 December 2020

Cushing's syndrome and bone

1 reference

12 December 2020

Normal bone mineral density following cure of Cushing's syndrome

1 reference

12 December 2020

Effects of Child- and Adolescent-Onset Endogenous Cushing Syndrome on Bone Mass, Body Composition, and Growth: A 7-Year Prospective Study Into Young Adulthood

1 reference

12 December 2020

The survival and well-being of patients treated for Cushing's syndrome

1 reference

12 December 2020

Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission

1 reference

12 December 2020

The natural history of Cushing's syndrome

1 reference

12 December 2020

Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma

1 reference

12 December 2020

Subtle cognitive impairments in patients with long-term cure of Cushing's disease.

1 reference

12 December 2020

Memory impairment in Cushing's disease.

1 reference

12 December 2020

The Longitudinal Course of Psychopathology in Cushing’s Syndrome after Correction of Hypercortisolism

1 reference

12 December 2020

10.1007/S11102-012-0394-8

Identifiers

DOI

1 reference

26 August 2017

1 reference